Connect with us

Public Companies

News You Might Have Missed – September 21, 2021

The article News You Might Have Missed – September 21, 2021 was originally published on Microdose.

Published

on

The article News You Might Have Missed – September 20, 2021 was originally published on Microdose. News You Might Have Missed – September 20, 2021 Welcome to the News You Might Have Missed, a weekly roundup of news items to help you catch up and stay informed. It was a busy week with lots of news, have a look and see you next week for another update. Algernon Pharmaceuticals Announces Plans for a Phase 2 Ifenprodil Chronic Cough Study in the U.S. The company announces that it plans to file a pre-IND (Investigational New Drug) meeting request with the U.S. Food and Drug Administration (U.S. FDA) for an NP-120 (Ifenprodil) Phase 2 chronic cough study. Read more PsyBio Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update The company reported its unaudited financial results for the three-month period ended June 30, 2021 and provided shareholders with a corporate update. Read more Enveric Biosciences Announces Closing of MagicMed Industries Acquisition Enveric intends to immediately accelerate the development of a novel Psychedelic molecule for Cancer Related Distress. Read more NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board Company Broadens Scientific Expertise with Addition of Mental Health Expert in Setting Up and Managing Interventional Psychiatric Clinics. Read more AdvisorShares’ New Psychedelic ETF Launches on the NYSE The first actively managed fund, the “PSIL” ETF is another step forward for the psychedelic medicine industry. Read more

Read More

Trending